In conclusion, G‐CSF‐producing lung tumours can manifest as sterile lung abscesses, and tepotinib therapy may effectively target these tumours in patients with MET exon 14 skipping mutations, even in cases of G‐CSF‐producing lung cancer. The gene discussed is MET; the disease is lung abscess.